Simultaneous quantitation of zidovudine, efavirenz, lopinavir and ritonavir in human hair by liquid chromatography-atmospheric pressure chemical ionization-tandem mass spectrometry.

[1]  C. Orrell,et al.  A validated liquid chromatography/tandem mass spectrometry method for the analysis of efavirenz in 0.2 mg hair samples from human immunodeficiency virus infected patients. , 2018, Rapid communications in mass spectrometry : RCM.

[2]  Xiaomin Li,et al.  Simultaneous determination of antiretroviral drugs in human hair with liquid chromatography-electrospray ionization-tandem mass spectrometry. , 2018, Journal of chromatography. B, Analytical technologies in the biomedical and life sciences.

[3]  L. Nováková,et al.  Current antiviral drugs and their analysis in biological materials – Part II: Antivirals against hepatitis and HIV viruses , 2018, Journal of pharmaceutical and biomedical analysis.

[4]  Arindam Mukhopadhyay,et al.  A LC–MS/MS method with column coupling technique for simultaneous estimation of lamivudine, zidovudine, and nevirapine in human plasma , 2016, Journal of Analytical Science and Technology.

[5]  H. Xing,et al.  Lamivudine Concentration in Hair and Prediction of Virologic Failure and Drug Resistance among HIV Patients Receiving Free ART in China , 2016, PloS one.

[6]  Yachen Deng,et al.  Rapid identification of efavirenz metabolites in rats and humans by ultra high performance liquid chromatography combined with quadrupole time-of-flight tandem mass spectrometry. , 2015, Journal of separation science.

[7]  P. Bacchetti,et al.  Comparing the Novel Method of Assessing PrEP Adherence/Exposure Using Hair Samples to Other Pharmacologic and Traditional Measures , 2014, Journal of acquired immune deficiency syndromes.

[8]  M. Belay,et al.  Adherence to Antiretroviral Therapy and associated factors among HIV infected children in Ethiopia: unannounced home-based pill count versus caregivers’ report , 2013, BMC Pediatrics.

[9]  Wei Gao,et al.  Simultaneous determination of hair cortisol, cortisone and DHEAS with liquid chromatography-electrospray ionization-tandem mass spectrometry in negative mode. , 2013, Journal of chromatography. B, Analytical technologies in the biomedical and life sciences.

[10]  J. Ananworanich,et al.  Second-Line Protease Inhibitor-Based Haart after Failing Non-Nucleoside Reverse Transcriptase Inhibitor-Based Regimens in Asian HIV-Infected Children , 2013, Antiviral therapy.

[11]  H. Rosing,et al.  Development and validation of an assay for the simultaneous determination of zidovudine, abacavir, emtricitabine, lamivudine, tenofovir and ribavirin in human plasma using liquid chromatography-tandem mass spectrometry. , 2013, Journal of chromatography. B, Analytical technologies in the biomedical and life sciences.

[12]  A. Petróczi,et al.  Simultaneous analysis of antiretroviral drugs abacavir and tenofovir in human hair by liquid chromatography-tandem mass spectrometry. , 2013, Journal of pharmaceutical and biomedical analysis.

[13]  R. Kronstrand,et al.  Society of Hair Testing guidelines for drug testing in hair. , 2012, Forensic science international.

[14]  Graeme Smith.  European Medicines Agency guideline on bioanalytical method validation: what more is there to say? , 2012, Bioanalysis.

[15]  D. Banji,et al.  Simultaneous determination of efavirenz, lamivudine and tenofovir disoproxil fumerate in tablet dosage form by using RP-HPLC , 2012 .

[16]  Lizheng Shi,et al.  Concordance of Adherence Measurement Using Self-Reported Adherence Questionnaires and Medication Monitoring Devices , 2012, PharmacoEconomics.

[17]  R. Greenblatt,et al.  Microanalysis of the antiretroviral nevirapine in human hair from HIV-infected patients by liquid chromatography-tandem mass spectrometry , 2011, Analytical and bioanalytical chemistry.

[18]  P. Reiss,et al.  The Lopinavir/Ritonavir-Associated Rise in Lipids is not Related to Lopinavir or Ritonavir Plasma Concentration , 2011, Antiviral therapy.

[19]  M. Ekstrand,et al.  Suboptimal adherence associated with virological failure and resistance mutations to first-line highly active antiretroviral therapy (HAART) in Bangalore, India. , 2011, International health.

[20]  D. Cromarty,et al.  Determination of salivary efavirenz by liquid chromatography coupled with tandem mass spectrometry. , 2010, Journal of chromatography. B, Analytical technologies in the biomedical and life sciences.

[21]  Lizheng Shi,et al.  Correlation between adherence rates measured by MEMS and self-reported questionnaires: a meta-analysis , 2010, Health and quality of life outcomes.

[22]  V. Haufroid,et al.  Validation and clinical application of a high performance liquid chromatography tandem mass spectrometry (LC-MS/MS) method for the quantitative determination of 10 anti-retrovirals in human peripheral blood mononuclear cells. , 2009, Journal of chromatography. B, Analytical technologies in the biomedical and life sciences.

[23]  C. Katlama,et al.  Influence of antigen exposure on the loss of long-term memory to childhood vaccines in HIV-infected patients. , 2009, Vaccine.

[24]  A. Telenti,et al.  A LC-tandem MS assay for the simultaneous measurement of new antiretroviral agents: Raltegravir, maraviroc, darunavir, and etravirine. , 2009, Journal of chromatography. B, Analytical technologies in the biomedical and life sciences.

[25]  David R. Holtgrave,et al.  Factors associated with adherence to highly active antiretroviral therapy in homeless or unstably housed adults living with HIV , 2009, AIDS care.

[26]  Mardge H. Cohen,et al.  Protease inhibitor levels in hair strongly predict virologic response to treatment , 2009, AIDS.

[27]  M. Dybul,et al.  Evolution of drug resistance after virological failure of a first-line highly active antiretroviral therapy regimen in Uganda , 2009, Antiviral therapy.

[28]  R. Greenblatt,et al.  Sensitive analysis of anti-HIV drugs, efavirenz, lopinavir and ritonavir, in human hair by liquid chromatography coupled with tandem mass spectrometry. , 2008, Rapid communications in mass spectrometry : RCM.

[29]  G. di Perri,et al.  HPLC-MS method for the simultaneous quantification of the new HIV protease inhibitor darunavir, and 11 other antiretroviral agents in plasma of HIV-infected patients. , 2007, Journal of chromatography. B, Analytical technologies in the biomedical and life sciences.

[30]  B. Jung,et al.  Simultaneous determination of 17 antiretroviral drugs in human plasma for quantitative analysis with liquid chromatography-tandem mass spectrometry. , 2007, Biomedical chromatography : BMC.

[31]  Evan Wood,et al.  Continued improvement in survival among HIV-infected individuals with newer forms of highly active antiretroviral therapy , 2007, AIDS.

[32]  C. Leport,et al.  Hair versus plasma concentrations as indicator of indinavir exposure in HIV-1-infected patients treated with indinavir/ritonavir combination , 2007, AIDS.

[33]  J. Fisher,et al.  Visual Analog Scale of ART Adherence: Association With 3-Day Self-Report and Adherence Barriers , 2006, Journal of acquired immune deficiency syndromes.

[34]  Hélène Budzinski,et al.  Simultaneous determination of the antiretroviral agents: amprenavir, lopinavir, ritonavir, saquinavir and efavirenz in human peripheral blood mononuclear cells by high-performance liquid chromatography-mass spectrometry. , 2004, Journal of chromatography. B, Analytical technologies in the biomedical and life sciences.

[35]  R. Yogev,et al.  Rapid Human Immunodeficiency Virus Decay in Highly Active Antiretroviral Therapy (HAART)-Experienced Children after Starting Mega-HAART , 2004, Journal of Virology.

[36]  G. Maga,et al.  HIV-1 reverse transcriptase inhibitors: current issues and future perspectives. , 2004, Current drug metabolism.

[37]  M. Maurin,et al.  Kinetics and Mechanism of Hydrolysis of Efavirenz , 2002, Pharmaceutical Research.

[38]  W. Lambert,et al.  Matrix effect in bio-analysis of illicit drugs with LC-MS/MS: Influence of ionization type, sample preparation, and biofluid , 2003, Journal of the American Society for Mass Spectrometry.

[39]  H. Sachs,et al.  Proficiency test for the analysis of hair for drugs of abuse, organized by the Society of Hair Testing. , 2003, Forensic science international.

[40]  A. Antinori,et al.  Treatment‐Related Factors and Highly Active Antiretroviral Therapy Adherence , 2002, Journal of acquired immune deficiency syndromes.

[41]  R. Greenblatt,et al.  Hair It Is: The Long and Short of Monitoring Antiretroviral Treatment , 2002, Annals of Internal Medicine.

[42]  M. Eberlin,et al.  Atmospheric pressure photoionization mass spectrometry. Ionization mechanism and the effect of solvent on the ionization of naphthalenes. , 2002, Analytical chemistry.

[43]  Risto Kostiainen,et al.  Liquid chromatography/mass spectrometry in anabolic steroid analysis--optimization and comparison of three ionization techniques: electrospray ionization, atmospheric pressure chemical ionization and atmospheric pressure photoionization. , 2002, Journal of mass spectrometry : JMS.

[44]  J. Smeraglia,et al.  Matrix effects and selectivity issues in LC-MS-MS , 2002 .

[45]  A. Wu,et al.  Self‐Reported Symptoms and Medication Side Effects Influence Adherence to Highly Active Antiretroviral Therapy in Persons With HIV Infection , 2001, Journal of acquired immune deficiency syndromes.

[46]  J. Dunn,et al.  Simultaneous determination of zidovudine and lamivudine in human serum using HPLC with tandem mass spectrometry. , 2000, Journal of pharmaceutical and biomedical analysis.

[47]  Y. Nakahara.  Hair analysis for abused and therapeutic drugs. , 1999, Journal of chromatography. B, Biomedical sciences and applications.

[48]  C. Fletcher.  Pharmacologic Considerations for Therapeutic Success with Antiretroviral Agents , 1999, The Annals of pharmacotherapy.

[49]  F. Pragst,et al.  Illegal and Therapeutic Drug Concentrations in Hair Segments - A Timetable of Drug Exposure? , 1998, Forensic science review.

[50]  A. J. Wright,et al.  Recent advances in the management of human immunodeficiency virus infection. , 1997, Mayo Clinic proceedings.

[51]  S. Vella.  Rationale and experience with reverse transcriptase inhibitors and protease inhibitors. , 1995, Journal of acquired immune deficiency syndromes and human retrovirology : official publication of the International Retrovirology Association.

[52]  L. Perrin,et al.  Therapeutic interventions in primary HIV infection. , 1995, Journal of acquired immune deficiency syndromes and human retrovirology : official publication of the International Retrovirology Association.

[53]  B. Larder,et al.  Viral resistance and the selection of antiretroviral combinations. , 1995, Journal of acquired immune deficiency syndromes and human retrovirology : official publication of the International Retrovirology Association.